PIPA5122132

CD164 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5122132-Each-of-1 In Stock ₹ 17,346.10

PIPA5122132 - Each of 1

₹ 17,346.10

In Stock

Quantity

1

Base Price: ₹ 17,346.10

GST (18%): ₹ 3,122.298

Total Price: ₹ 20,468.398

Antigen

CD164

Classification

Polyclonal

Conjugate

Unconjugated

Gene

CD164

Gene Alias

A115; A24; AA589639; AW540279; Cd164; CD164 antigen; CD164 antigen, sialomucin; CD164 molecule; CD164 molecule, sialomucin; CD164 variant C; c-Myc binding protein; deafness, autosomal dominant 66; DFNA66; endolyn; MGC-24; MGC-24v; MSSP; MUC-24; Multi-glycosylated core protein 24; sialomucin core protein 24

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

53599

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Concentration

0.99 mg/mL

Formulation

PBS with 50% glycerol and 0.05% ProClin 300

Gene Accession No.

Q9R0L9

Gene Symbols

CD164

Immunogen

Recombinant protein Cluster Of Differentiation 164. The antigen corresponds to amino acid range 24-162 of the target protein.

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Mouse

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5122131

--

Img

Thermo Scientific

PIPA5121974

--

Img

Thermo Scientific

PIPA5122085

--

Img

Thermo Scientific

PIPA5121564

--

Img

Thermo Scientific

PIPA5122086

--

Img

Thermo Scientific

PIPA5122170

--

Img

Thermo Scientific

PIPA5122307

--

Img

Thermo Scientific

PIPA5122148

--

Description

  • This gene encodes a transmembrane sialomucin and cell adhesion molecule that regulates the proliferation, adhesion and migration of hematopoietic progenitor cells
  • The encoded protein also interacts with the C-X-C chemokine receptor type 4 and may regulate muscle development
  • Elevated expression of this gene has been observed in human patients with Sezary syndrome, a type of blood cancer, and a mutation in this gene may be associated with impaired hearing.